1.
Full Text
The TGFβ pathway stimulates ovarian cancer cell proliferation by increasing IGF1R levels
International Journal of Cancer, ISSN 0020-7136, 10/2016, Volume 139, Issue 8, pp. 1894 - 1903
In a search for new therapeutic targets for treating epithelial ovarian cancer, we analyzed the Transforming Growth Factor Beta (TGFβ) signaling pathway in...
TGFβ | epithelial ovarian tumors | IGF1R | Epithelial ovarian tumors | INSULIN | PATHOGENESIS | LY2109761 | TARGET | ONCOLOGY | BIOLOGY | GROWTH-FACTOR | TGF beta | EXPRESSION | Neoplasms, Glandular and Epithelial - pathology | Antibodies, Monoclonal - pharmacology | Humans | Cell Proliferation - physiology | Ovarian Neoplasms - pathology | Neoplasms, Glandular and Epithelial - metabolism | Random Allocation | Pyrroles - pharmacology | Animals | Heterografts | Signal Transduction - drug effects | Mice, Nude | Receptors, Somatomedin - metabolism | Neoplasms, Glandular and Epithelial - drug therapy | Carcinoma, Ovarian Epithelial | Transforming Growth Factor beta - antagonists & inhibitors | Female | Mice | Ovarian Neoplasms - metabolism | Ovarian Neoplasms - drug therapy | Transforming Growth Factor beta - metabolism | Pyrazoles - pharmacology | Factors de creixement | Cell proliferation | Càncer d'ovari | Proliferació cel·lular | Cèl·lules epitelials | Insulin receptors | Epithelial cells | Receptors d'insulina | Growth factors | Ovarian cancer
TGFβ | epithelial ovarian tumors | IGF1R | Epithelial ovarian tumors | INSULIN | PATHOGENESIS | LY2109761 | TARGET | ONCOLOGY | BIOLOGY | GROWTH-FACTOR | TGF beta | EXPRESSION | Neoplasms, Glandular and Epithelial - pathology | Antibodies, Monoclonal - pharmacology | Humans | Cell Proliferation - physiology | Ovarian Neoplasms - pathology | Neoplasms, Glandular and Epithelial - metabolism | Random Allocation | Pyrroles - pharmacology | Animals | Heterografts | Signal Transduction - drug effects | Mice, Nude | Receptors, Somatomedin - metabolism | Neoplasms, Glandular and Epithelial - drug therapy | Carcinoma, Ovarian Epithelial | Transforming Growth Factor beta - antagonists & inhibitors | Female | Mice | Ovarian Neoplasms - metabolism | Ovarian Neoplasms - drug therapy | Transforming Growth Factor beta - metabolism | Pyrazoles - pharmacology | Factors de creixement | Cell proliferation | Càncer d'ovari | Proliferació cel·lular | Cèl·lules epitelials | Insulin receptors | Epithelial cells | Receptors d'insulina | Growth factors | Ovarian cancer
Journal Article
Gaceta medica de Mexico, ISSN 0016-3813, 01/2017, Volume 153, Issue 7, pp. 852 - 863
Free fatty acids are essential nutritional components and recent studies identified them as signaling molecules in various physiological processes. It has now...
Insulin resistance | Insulin receptor | Fatty acids | Insulin receptor substrate | Protein Kinases - metabolism | Cardiovascular Diseases - etiology | Obesity | Ceramides - metabolism | Fatty Acids, Nonesterified - physiology | Insulin - physiology | Humans | Oxidative Stress - physiology | Insulin Resistance - physiology | Diabetes Mellitus, Type 2 - etiology | Toll-Like Receptors - metabolism | Dyslipidemias - etiology | Endoplasmic Reticulum Stress - physiology
Insulin resistance | Insulin receptor | Fatty acids | Insulin receptor substrate | Protein Kinases - metabolism | Cardiovascular Diseases - etiology | Obesity | Ceramides - metabolism | Fatty Acids, Nonesterified - physiology | Insulin - physiology | Humans | Oxidative Stress - physiology | Insulin Resistance - physiology | Diabetes Mellitus, Type 2 - etiology | Toll-Like Receptors - metabolism | Dyslipidemias - etiology | Endoplasmic Reticulum Stress - physiology
Journal Article
3.
Síndrome de insulinorresistencia severa tipo A debido a mutación del gen del receptor de insulina
Anales de pediatria (Barcelona, Spain : 2003), 01/2015, Volume 82, Issue 1, pp. e30 - e34
Insulin resistance syndromes without lipodystrophy are an infrequent and heterogeneous group of disorders with variable clinical phenotypes, associated with...
Tyrosine kinase | Insulin receptor mutation | Mutación del receptor de insulina | Insulinorresistencia | Hiperandrogenismo | Hyperandrogenism | Insulin resistance | Acanthosis nigricans | Tirosinquinasa | Acantosis nigricans
Tyrosine kinase | Insulin receptor mutation | Mutación del receptor de insulina | Insulinorresistencia | Hiperandrogenismo | Hyperandrogenism | Insulin resistance | Acanthosis nigricans | Tirosinquinasa | Acantosis nigricans
Journal Article
Redox Biology, ISSN 2213-2317, 10/2017, Volume 13, Issue C, pp. 345 - 352
The aim of the present study is to elucidate the neuronal pathways associated to NSAIDs causing a reduction of the risk and progression of Alzheimer's disease....
APPSwe/PS1dE9 | Memory impairment | Mitochondria | Dexibuprofen | TAU | Insulin receptor | Alzheimer's disease | Hippocampus | APP/PS1 MICE | ALZHEIMERS-DISEASE | BIOCHEMISTRY & MOLECULAR BIOLOGY | TRANSGENIC MODEL | PATHOLOGY | PATHOGENESIS | ANTIINFLAMMATORY AGENTS | NEUROINFLAMMATION | INFLAMMATION | IN-VIVO | MOUSE MODEL | Neuroprotective Agents - therapeutic use | Tumor Necrosis Factor-alpha - metabolism | Amyloid Precursor Protein Secretases - genetics | Ibuprofen - therapeutic use | tau Proteins - metabolism | Cognition | Aspartic Acid Endopeptidases - genetics | Phosphoproteins - metabolism | Ibuprofen - analogs & derivatives | Brain - metabolism | Neuroprotective Agents - pharmacology | Cyclins - metabolism | Female | Ibuprofen - pharmacology | Signal Transduction | Mice, Inbred C57BL | Alzheimer Disease - drug therapy | Presenilin-1 - genetics | Cyclin-Dependent Kinase 5 - metabolism | Brain - drug effects | Amyloid Precursor Protein Secretases - metabolism | Amyloid beta-Protein Precursor - genetics | Animals | Carrier Proteins - metabolism | Aspartic Acid Endopeptidases - metabolism | Proto-Oncogene Proteins c-abl - metabolism | Mice | Alzheimer Disease - genetics | Index Medicus | Drugs | Malaltia d'Alzheimer | Medicaments | Insulin receptors | Receptors d'insulina | Hippocampus (Brain) | Hipocamp (Cervell) | Mitocondris
APPSwe/PS1dE9 | Memory impairment | Mitochondria | Dexibuprofen | TAU | Insulin receptor | Alzheimer's disease | Hippocampus | APP/PS1 MICE | ALZHEIMERS-DISEASE | BIOCHEMISTRY & MOLECULAR BIOLOGY | TRANSGENIC MODEL | PATHOLOGY | PATHOGENESIS | ANTIINFLAMMATORY AGENTS | NEUROINFLAMMATION | INFLAMMATION | IN-VIVO | MOUSE MODEL | Neuroprotective Agents - therapeutic use | Tumor Necrosis Factor-alpha - metabolism | Amyloid Precursor Protein Secretases - genetics | Ibuprofen - therapeutic use | tau Proteins - metabolism | Cognition | Aspartic Acid Endopeptidases - genetics | Phosphoproteins - metabolism | Ibuprofen - analogs & derivatives | Brain - metabolism | Neuroprotective Agents - pharmacology | Cyclins - metabolism | Female | Ibuprofen - pharmacology | Signal Transduction | Mice, Inbred C57BL | Alzheimer Disease - drug therapy | Presenilin-1 - genetics | Cyclin-Dependent Kinase 5 - metabolism | Brain - drug effects | Amyloid Precursor Protein Secretases - metabolism | Amyloid beta-Protein Precursor - genetics | Animals | Carrier Proteins - metabolism | Aspartic Acid Endopeptidases - metabolism | Proto-Oncogene Proteins c-abl - metabolism | Mice | Alzheimer Disease - genetics | Index Medicus | Drugs | Malaltia d'Alzheimer | Medicaments | Insulin receptors | Receptors d'insulina | Hippocampus (Brain) | Hipocamp (Cervell) | Mitocondris
Journal Article
5.
Full Text
Characterization data of gilthead sea bream (Sparus aurata) IGF-I receptors (IGF-IRa/Rb)
Data in Brief, ISSN 2352-3409, 03/2016, Volume 6, pp. 507 - 513
In this data article we describe the coding sequence of two IGF-IR paralogues (IGF-IRa and IGF-IRb) obtained from gilthead sea bream embryos. The putative...
IGF-I receptors | Gilthead sea bream | Miogènesi | Sparus aurata | Insulin receptors | Orada | Receptors d'insulina | Gene expression | Expressió gènica | Myogenesis
IGF-I receptors | Gilthead sea bream | Miogènesi | Sparus aurata | Insulin receptors | Orada | Receptors d'insulina | Gene expression | Expressió gènica | Myogenesis
Journal Article
Nutricion Hospitalaria, ISSN 0212-1611, 2014, Volume 29, Issue 6, pp. 1327 - 1334
Journal Article
Sao Paulo Medical Journal, ISSN 1516-3180, 12/2011, Volume 129, Issue 6, pp. 387 - 391
Journal Article
Neurologia, ISSN 0213-4853, 2014, Volume 29, Issue 7, pp. 408 - 415
Introduction: Many studies have demonstrated that iron deficiency modifies the normal function of the central nervous system and alters cognitive abilities....
Cell cultures | Insulin-like growth factor II | Iron deficiency | Growth factors | Central nervous system | Specific receptor of insulin-like growth factor II
Cell cultures | Insulin-like growth factor II | Iron deficiency | Growth factors | Central nervous system | Specific receptor of insulin-like growth factor II
Journal Article
1988, Receptor biochemistry and methodology, ISBN 9780845137994, Volume 12, 2 pt.
Book
Acta Scientiarum - Biological Sciences, ISSN 1679-9283, 2013, Volume 35, Issue 3, pp. 437 - 443
Journal Article
11.
Insulin and IGFs
2009, 1st ed., Vitamins and hormones, ISBN 0123744083, Volume 80., xxii, 733 p., [16] p. of plates
First published in 1943, Vitamins and Hormones is the longest-running serial published by Academic Press. The Editorial Board now reflects expertise in the...
Somatomedin | Insulin
Somatomedin | Insulin
Book
1989, Ellis Horwood books in the biological sciences. Series in biotechnology., ISBN 074580473X, 129
Book
Nutrición Hospitalaria, ISSN 0212-1611, 10/2012, Volume 27, Issue 5, pp. 1637 - 1642
Background: Considering the evidence that endogenous cannabinoid system plays a role in metabolic aspects of body weight and metabolic syndrome components such...
Esteatosis. Polimorfismo | Adipocitoquinas | Resistencia a la insulina | Cannabinoid receptor gene | Insulin resistance | Adipokines | Gen del receptor canabi-noide | Steatosis | Polymorphism
Esteatosis. Polimorfismo | Adipocitoquinas | Resistencia a la insulina | Cannabinoid receptor gene | Insulin resistance | Adipokines | Gen del receptor canabi-noide | Steatosis | Polymorphism
Journal Article
Arquivos Brasileiros de Endocrinologia e Metabologia, ISSN 0004-2730, 11/2011, Volume 55, Issue 8, pp. 541 - 549
Aproximadamente 10% das crianças nascidas pequenas para a idade gestacional (PIGs) não apresentam recuperação espontânea do crescimento. As causas desse...
Mutation | Fetal growth retardation | Insulin-like growth factor I | Receptor | IGF type 1 | Growth disorders | ENDOCRINOLOGY & METABOLISM
Mutation | Fetal growth retardation | Insulin-like growth factor I | Receptor | IGF type 1 | Growth disorders | ENDOCRINOLOGY & METABOLISM
Journal Article
Brain, ISSN 0006-8950, 12/2017, Volume 140, Issue 12, pp. 3269 - 3285
Insulin signalling deficiencies and insulin resistance have been directly linked to the progression of neurodegenerative disorders like Alzheimer's disease....
tau | insulin | Alzheimer's disease | oligomers | neurofibrillary tangles | RECEPTOR SUBSTRATE | ALZHEIMERS-DISEASE | NEUROSCIENCES | CLINICAL NEUROLOGY | MOUSE MODEL | IN-VIVO | A-BETA | MIDDLE-AGED ADULTS | DEGRADING ENZYME | GLUCOSE-UPTAKE | GROWTH-FACTOR EXPRESSION | BRAIN | Phosphorylation | Humans | Middle Aged | Insulin Resistance | tau Proteins - metabolism | Male | Brain - metabolism | Insulin - metabolism | Alzheimer Disease - metabolism | Aged, 80 and over | Supranuclear Palsy, Progressive - metabolism | Female | Aged | Neurons - metabolism | Malaltia d'Alzheimer | Brain | Resistència a la insulina | Neurones | Neurons | Cervell | Insulin resistance | Metabolisme | Metabolism
tau | insulin | Alzheimer's disease | oligomers | neurofibrillary tangles | RECEPTOR SUBSTRATE | ALZHEIMERS-DISEASE | NEUROSCIENCES | CLINICAL NEUROLOGY | MOUSE MODEL | IN-VIVO | A-BETA | MIDDLE-AGED ADULTS | DEGRADING ENZYME | GLUCOSE-UPTAKE | GROWTH-FACTOR EXPRESSION | BRAIN | Phosphorylation | Humans | Middle Aged | Insulin Resistance | tau Proteins - metabolism | Male | Brain - metabolism | Insulin - metabolism | Alzheimer Disease - metabolism | Aged, 80 and over | Supranuclear Palsy, Progressive - metabolism | Female | Aged | Neurons - metabolism | Malaltia d'Alzheimer | Brain | Resistència a la insulina | Neurones | Neurons | Cervell | Insulin resistance | Metabolisme | Metabolism
Journal Article
DIABETES CARE, ISSN 0149-5992, 05/2018, Volume 41, Issue 5, pp. 1009 - 1016
OBJECTIVE In patients with uncontrolled type 2 diabetes on basal insulin, prandial insulin may be initiated. We assessed the efficacy and safety of initiating...
FIXED-RATIO COMBINATION | MANAGEMENT | ENDOCRINOLOGY & METABOLISM | HYPOGLYCEMIA | GLP-1 RECEPTOR AGONIST | INERTIA | LIRAGLUTIDE IDEGLIRA | DEGLUDEC | DEGLUDEC/LIRAGLUTIDE | Glycated Hemoglobin A - analysis | Humans | Middle Aged | Male | Metformin - adverse effects | Insulin Glargine - administration & dosage | Insulin Aspart - administration & dosage | Hypoglycemic Agents - administration & dosage | Adult | Female | Metformin - administration & dosage | Drug Therapy, Combination | Insulin Glargine - adverse effects | Insulin - administration & dosage | Treatment Outcome | Blood Glucose - drug effects | Insulin, Long-Acting - adverse effects | Insulin, Long-Acting - administration & dosage | Liraglutide - adverse effects | Aged | Liraglutide - administration & dosage | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Insulin - adverse effects | Insulin Aspart - adverse effects | Drug Combinations | Type 2 diabetes | Care and treatment | Control | Blood sugar | Analysis | Hemoglobin | Diagnosis | Research | Hypoglycemia | Drug therapy | Insulin
FIXED-RATIO COMBINATION | MANAGEMENT | ENDOCRINOLOGY & METABOLISM | HYPOGLYCEMIA | GLP-1 RECEPTOR AGONIST | INERTIA | LIRAGLUTIDE IDEGLIRA | DEGLUDEC | DEGLUDEC/LIRAGLUTIDE | Glycated Hemoglobin A - analysis | Humans | Middle Aged | Male | Metformin - adverse effects | Insulin Glargine - administration & dosage | Insulin Aspart - administration & dosage | Hypoglycemic Agents - administration & dosage | Adult | Female | Metformin - administration & dosage | Drug Therapy, Combination | Insulin Glargine - adverse effects | Insulin - administration & dosage | Treatment Outcome | Blood Glucose - drug effects | Insulin, Long-Acting - adverse effects | Insulin, Long-Acting - administration & dosage | Liraglutide - adverse effects | Aged | Liraglutide - administration & dosage | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Insulin - adverse effects | Insulin Aspart - adverse effects | Drug Combinations | Type 2 diabetes | Care and treatment | Control | Blood sugar | Analysis | Hemoglobin | Diagnosis | Research | Hypoglycemia | Drug therapy | Insulin
Journal Article
2002, Frontiers in animal diabetes research, ISBN 9780415271745, Volume 3, xviii, 423
With contributions from the leading researchers in the field, this volume brings together the latest studies on insulin action and signal transduction to...
metabolism | Receptors, Insulin | Diabetes | Insulin | Cellular signal transduction
metabolism | Receptors, Insulin | Diabetes | Insulin | Cellular signal transduction
Book
Book
1979, ISBN 0890043019, xv, 260
Book
Nutrición Hospitalaria, ISSN 0212-1611, 02/2010, Volume 25, Issue 1, pp. 34 - 38
Background: A silent intragenic biallelic polymorphism (1359 G/A) (rs1049353) of the CB1 gene resulting in the substitution of the G to A at nucleotide...
Gen del receptor cannabinoide | Diabetes mellitus | Insulin resistencia | Cannabinoid receptor gene | Insulin resistance | Polimorfismo | Polymorphism
Gen del receptor cannabinoide | Diabetes mellitus | Insulin resistencia | Cannabinoid receptor gene | Insulin resistance | Polimorfismo | Polymorphism
Journal Article
No results were found for your search.
Cannot display more than 1000 results, please narrow the terms of your search.